Immigration Status and Time to Accessing Publicly Funded Flash Glucose Monitoring Systems

• by Mary N. Elias, Sara Allin, Joanna Yang, Maria Chiu, Baiju R. Shah, Fangyun Wu, Tara Gomes

• June 2, 2026

Diabetic Retinal Disease Rates Narrow by Diabetes Type

US claims data showed rising prevalence of diabetic retinal disease in type 1 and type 2 diabetes, while incidence declined in type 1 diabetes and moved closer to type 2 rates by 2022.

• by Andrea Surnit

• April 15, 2026

• 5 min

Could Wegovy Raise Optic Nerve Risk?

A pharmacovigilance analysis of FDA adverse event reports finds the strongest ischemic optic neuropathy reporting signal with high-dose semaglutide formulations, with higher adjusted odds reported in men.

• by Kerri Miller

• March 11, 2026

• 5 min

AACE 2026: Will AI replace endocrinologists?

The same technology drawing patients away from clinic may also improve the patient-physician relationship.

• by Jared Bilski

• April 22, 2026

• 3 min